Treatment of anemia with Aranesp™ (darbepoetin alfa) improves health related quality of life (HRQOL) in patients with chronic kidney disease (CKD).

被引：0
|
作者：
Thadhani, R
Cheriyan, R
Brenner, R
Ford, J
Powers, K
Rahman, SN
机构：
[1] Univ Texas, Hlth Sci Ctr, Houston, TX USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Virginia Nephrol Grp, Fairfax, VA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：637A / 637A
页数：1
相关论文
共 50 条
  • [41] Effect of anemia treatment with epoetin alfa or darbepoetin alfa on left ventricular mass in patients with chronic kidney disease not on dialysis in Japan.
    Suzuki, Makoto
    Akaishi, Makoto
    Hada, Yoshiyuki
    Hiroe, Michiaki
    Aonuma, Kazutaka
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 67A - 67A
  • [42] Managing anemia in patients with chronic kidney disease or cancer: Development and role of darbepoetin alfa - Introduction
    Scott, SD
    PHARMACOTHERAPY, 2002, 22 (09): : 129S - 132S
  • [43] The effect of every-other-week (Q2W) darbepoetin alfa on hemoglobin (HB) levels and health-related quality of life (HRQOL) in older chronic kidney disease (CKD) patients naive to recombinant human erythropoietin (RHUEPO).
    Abu-Alfa, A
    Hertel, J
    Locay, H
    Scarlata, D
    Globe, D
    Audhya, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S71 - S71
  • [44] Treatment patterns of anemia in patients with chronic kidney disease (CKD).
    Rao, M
    Pereira, B
    Scarlata, D
    Brenner, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 816A - 816A
  • [45] Anemia and health-related quality of life in adolescents with chronic kidney disease
    Gerson, A
    Hwang, W
    Fiorenza, J
    Barth, K
    Kaskel, F
    Weiss, L
    Zelikovsky, N
    Fivush, B
    Furth, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (06) : 1017 - 1023
  • [46] Use of darbepoetin alfa for treatment of anemia associated with chronic kidney disease in pediatric bone marrow transplant patients.
    Barletta, GM
    Pietryga, D
    Abdel-Mageed, A
    Bunchman, TE
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 95 - 95
  • [47] Health related quality of life in patients with chronic kidney disease
    Kalantar-Zadeh K.
    Unruh M.
    International Urology and Nephrology, 2005, 37 (2) : 367 - 378
  • [48] Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease
    Gary Lerner
    Arundhati S. Kale
    Bradley A. Warady
    Kathy Jabs
    Timothy E. Bunchman
    Anne Heatherington
    Kurt Olson
    Louise Messer-Mann
    Bradley J. Maroni
    Pediatric Nephrology, 2002, 17 : 933 - 937
  • [49] Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease
    Lerner, G
    Kale, AS
    Warady, BA
    Jabs, K
    Bunchman, TE
    Heatherington, A
    Olson, K
    Messer-Mann, L
    Maroni, BJ
    PEDIATRIC NEPHROLOGY, 2002, 17 (11) : 935 - 939
  • [50] EXTEND: AN OBSERVATIONAL COHORT STUDY OF EXTENDED DOSING WITH ARANESP® (DARBEPOETIN ALFA) IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS - INTERIM ANALYSIS
    Suranyi, M. G.
    Tolman, C.
    NEPHROLOGY, 2009, 14 : A50 - A51
12345